Home

The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision is 'a world free of the intolerable burden of diseases of poverty within the coming decades'.

EVI is contributing to the global efforts to control these diseases in three main ways:

  • Creating an environment to accelerate the development and clinical assessment of vaccine candidates for diseases of poverty
  • Promoting affordability and accessibility of vaccines for diseases of poverty in low income populations
  • Seeking to align all major stakeholders and acting as a focal point to ensure the successful development of vaccines for diseases of poverty for low income populations.

TRANSVAC  Free Services
As part of the TRANSVAC project, a vaccine development platform offering free vaccine R&D facilities and services to European scientists, is available on application. The final cut-off date is 30 April 2013, 5pm CET.  Successful applicants  Apply now

EVI, Malaria, Diseases of Poverty Our portfolio
The EVI portfolio comprises four vaccine candidates under development, the coordination of five European Commission funded projects under the Sixth and Seventh Framework Programme, as well as one European and Developing Countries' Clinical Trials Partnership funded project.

Our achievements
EVI continues not only to have many successes in the clinical development of malaria vaccine candidates (its initial mandate as EMVI), but also in the coordination of projects funded by the European Commission (EC) and others. EVI intends to extend this success to include vaccine candidates for other diseases of poverty which fall under its wider mandate.